The problem of variants of unknown significance , or VUS, is not a new one. Whether a change in DNA sequence actually has any effect in practice is a question that has been with genomic diagnostics since the first clinical test, for BRCA, became available in 1996. (See BioWorld Insight, Jan. 28, 2013.)